Boston Family Office LLC Cuts Stake in The Clorox Company $CLX

Boston Family Office LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 29.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 17,203 shares of the company’s stock after selling 7,260 shares during the quarter. Boston Family Office LLC’s holdings in Clorox were worth $1,735,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CLX. Vermillion & White Wealth Management Group LLC bought a new position in Clorox during the 3rd quarter valued at about $25,000. Darwin Wealth Management LLC bought a new position in shares of Clorox in the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC lifted its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Ameriflex Group Inc. lifted its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after purchasing an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC bought a new position in shares of Clorox in the 4th quarter worth approximately $43,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.63% of the stock is owned by insiders.

Clorox Trading Down 1.6%

NYSE CLX opened at $96.74 on Friday. The company’s 50-day moving average price is $96.43 and its 200-day moving average price is $105.20. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a market cap of $11.70 billion, a PE ratio of 15.70, a PEG ratio of 0.51 and a beta of 0.56. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CLX shares. Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Jefferies Financial Group lowered their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research note on Friday, February 13th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, UBS Group lowered their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.